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patients with acute kidney injury (The
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randomized controlled trial’
Alexander Zarbock1*†, Joachim Gerß2†, Hugo Van Aken1, Andreea Boanta1, John A. Kellum3 and Melanie Meersch1Unfortunately, the original version of this article [1]
contained an error. There is a typo in one of the formulas
in the PDF version of this article on page six, though
the HTML version has the correct formula. To avoid
confusion the correct formula has been included here.
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